Stock Market News for February 23, 2026
754 news published.
Entertainment, leverage and box‑office momentum
AMC Entertainment Holdings (AMC) reported Q4 and full‑year 2025 results and filed a first‑lien notes offering with a conditional redemption, pairing operations and capital‑structure work investors will watch for refinancing costs and liquidity signals.
IMAX (IMAX) lit up the Chinese New Year box office with $28 million in ticket sales, reinforcing international recovery for theatrical content. In adjacent consumer betting, DraftKings (DKNG) launched an online sportsbook in Puerto Rico, expanding addressable users and monetization pathways for sports wagering.
AMC Networks (AMCX) announced an any‑and‑all exchange offer and consent solicitation for its 10.25% senior secured notes due 2029, a liability‑management move that could reshape near‑term cash interest and creditor dynamics across entertainment issuers.
Markets and trading — operations through extreme weather
ICE (NYSE) confirmed the New York Stock Exchange will open as scheduled despite a historic blizzard. That operational decision matters for intraday liquidity, options expirations and index rebalancing tied to heavy East Coast flows.
AeroMexico-related issuer updates (AERO) filed a current report on airport operational status, a reminder that travel and airline liquidity can be affected by regional disruptions.
M&A, mobility deals and strategic tuck‑ins
Uber (UBER) agreed to acquire parking app SpotHero, extending its urban‑mobility play into parking discovery and reservation. For investors, the deal broadens addressable services and potential take‑rates inside Uber’s ecosystem.
Veris Residential (VRE) remains in focus after the Affinius Capital‑led acquisition for $3.4 billion, lifting comparables in the residential REIT space.
Energy, mining and production moves
Ovintiv (OVV) reported Q4 and year‑end 2025 results, a data point for U.S. upstream margins, capital allocation and free cash‑flow plans as energy names balance returns and reinvestment.
Infinity Natural Resources (INR) completed a $1.2 billion acquisition of Ohio Utica assets, expanding production profiles and reserve assumptions for the operator.
Ero (ERO) released an inaugural PEA for Furnas, outlining a low‑capital‑intensity project with a 24‑year initial mine life—important for junior mining valuations and longer‑term nickel supply expectations.
Canaan Inc. (CAN) acquired Cipher Mining’s interest in multiple operational mining projects totaling ~4.4 EH/s in West Texas, a capacity boost that tightens supply dynamics in Bitcoin mining and could influence cost curves for larger crypto‑infrastructure players.
Aerospace, defense and nuclear technology
AST SpaceMobile (ASTS) was awarded a $30 million prime contract by the U.S. Space Development Agency, de‑risking backlog. Meanwhile, BWX Technologies (BWXT) reported Q4 and full‑year 2025 results and initiated 2026 guidance, a reminder that nuclear supply chains and government budgets remain key demand drivers for the defense‑adjacent industrial base.
Capital markets, financings and credit signals
Service Properties Trust (RMR) priced a $745 million ABS at 5.96% maturing 2031, a reference for property owners tapping securitization markets.
Ladder (LADR) closed $675 million in unsecured capital commitments and expanded revolver capacity to $1.25 billion, a liquidity move relevant to fintech lenders navigating rate volatility.
Tenaris (TS) terminated the second tranche of its USD 1.2 billion share buyback program, a signal that capital‑return plans can pivot quickly when cash flow or strategic priorities change—investors should watch management commentary on redeployment.
Dime Community Bank (DCOM) will rebrand as Dime Commercial Bank Company and transfer its listing to the New York Stock Exchange, a move that could broaden investor access and liquidity for the regional bank's shares.
Corporate strategy, recapitalizations and restructurings
Whirlpool (WHR) announced a strategic recapitalization to accelerate deleveraging and growth, a meaningful capital‑structure shift that could change leverage ratios and free cash‑flow allocation for buybacks or reinvestment.
Industrial tech, AI infrastructure and semiconductor supply chain
Keysight Technologies (KEYS) reported first‑quarter 2026 results, a bellwether for test and measurement demand across semiconductors and communications equipment in an era of AI ramp‑ups. Cadence (CDNS) completed the acquisition of Hexagon’s design and engineering business, strengthening simulation moats for complex chip design.
Novanta (NOVT) released Q4 and full‑year 2025 results, which investors will parse for order trends across lasers, photonics and precision‑motion markets tied to semiconductor and medical equipment demand.
Cybersecurity, networking and cloud services
Cloudflare (NET) said its SASE platform is the first to support modern post‑quantum encryption, a product differentiation that matters to enterprises planning long‑lived secure connections. Akamai (AKAM) announced an agentless zero‑trust segmentation solution powered by NVIDIA, a strategic tie‑up that could accelerate adoption of AI‑accelerated security stacks.
Payments, fintech and crypto infrastructure
Solana Company (HSDT) outlined plans for the Pacific Backbone, a high‑speed infrastructure buildout that could affect DeFi throughput. In a notable crypto‑finance tie‑up, Better (BETR) and Framework Ventures announced a strategic partnership to enable deployment of $500 million into Better via Sky’s stablecoin ecosystem, an example of new capital channels formed at the intersection of fintech and tokenized value.
Pharma commercialization, devices and diagnostics
Haemonetics (HAE) received FDA clearance for its NexSys® PCS plasma collection system with Persona® PLUS technology, a commercial inflection that may accelerate hospital adoption in plasma collection workflows.
Eli Lilly (LLY) announced Zepbound (tirzepatide) is now available in a multi‑dose KwikPen, improving dosing convenience and potentially accelerating uptake in weight‑management markets.
Biotech, oncology and rare‑disease catalysts
Vir Biotechnology (VIR) and Astellas announced a global strategic collaboration to advance PSMA‑targeting PRO‑XTEN® dual‑masked T‑cell engager VIR‑5500 for prostate cancer. Updated Phase 1 results show encouraging tolerability and activity, a program investors will watch for partnership economics and potential registrational pathing.
Arcus (RCUS) presented new data for its HIF‑2α inhibitor casdatifan showing progression‑free survival beyond one year in late‑line kidney cancer, a clinical signal that can meaningfully alter later‑stage development value and licensing conversations.
Tarveda (TARA)'s TARA‑002 showed a 68% complete response rate at six months in BCG‑unresponsive non‑muscle invasive bladder cancer—an efficacy readout that could fast‑track regulatory and commercial interest in a hard‑to‑treat indication.
Ultragenyx (RARE) received FDA acceptance and priority review of its BLA for DTX401, compressing the regulatory timeline for a potential gene‑therapy approval.
Medical devices and orthopedics
SI‑BONE (SIBN) reported record Q4 2025 results and issued 2026 guidance, a strong execution signal for orthopedic and minimally invasive spine markets. Adding distribution momentum, Smith+Nephew (SNN) signed a distribution agreement with SI‑BONE, which could broaden SI‑BONE’s commercial reach.
Buybacks and capital returns
Verisk Analytics (VRSK) advanced a $1.5 billion accelerated share repurchase, a near‑term EPS support mechanism.
Diagnostics, reimbursement and commercialization milestones
QT Imaging (QTI) achieved a major reimbursement advance with an AMA Category III CPT code for 3D breast ultrasound tomography, a commercialization inflection if hospitals adopt the technology. Myriad Genetics (MYGN) reported Q4 and FY2025 results and reiterated 2026 guidance, signaling stabilized execution in hereditary testing and diagnostics.
Earnings and scheduled reports investors are watching
Keysight Technologies (KEYS) — Q1 2026 results; watch backlog and instrument bookings tied to AI compute cycles.
BioMarin (BMRN) — Q4 and FY2025 results; rare‑disease revenue and pipeline cadence drive valuation.
Myriad Genetics (MYGN) — Q4 and FY2025 results; payer dynamics matter for margins.
Backblaze (BLZE) — Q4 and FY2025 results; storage economics and customer expansion may re‑rate multiples.
What to watch next
Deal integration: Uber’s SpotHero acquisition and distribution pacts like Smith+Nephew–SI‑BONE will test execution and cross‑sell potential.
Capital moves: Whirlpool’s recapitalization and Tenaris’s buyback termination are near‑term catalysts for leverage, buyback credibility and shareholder return expectations.
Clinical readouts: VIR‑5500, Arcus’s casdatifan data and TARA‑002 efficacy are binary events that can reprice biotech peers and partnership prospects.
Energy and mining economics: Ovintiv’s results, Ero’s Furnas PEA and Canaan’s mining capacity add could shift production forecasts and cost curves.
Payments and crypto capital: Better and Framework’s $500 million deployment via Sky’s stablecoin is an example of new funding channels investors should monitor for fintech scale and regulatory risk.
Stay ahead of the market with our list of today's most important stock news and financial updates. Whether you're a day trader, long-term investor, or market enthusiast, our news feed covers everything you need to know about publicly traded companies.
Our news feed is designed for investors who want to stay informed about the latest developments affecting their portfolio or watchlist. Whether you're researching potential investments, monitoring your current holdings, or simply staying up-to-date with market trends, our stock news page provides the information you need to make informed decisions.
What You'll Find on This Page:
- Breaking financial news and market-moving headlines
- FDA approvals and clinical trial results for biotech and pharma stocks
- Stock offerings, dividends, and other corporate actions
- Mergers, acquisitions, and strategic partnerships
- Business news affecting company performance and stock prices
- Easy-to-use tags for quick news categorization
- Stock tickers for instant company identification
- AI sentiment analysis to gauge market reaction
- Estimated impact scores to assess potential stock movement